1. Home
  2. NKTR vs MTA Comparison

NKTR vs MTA Comparison

Compare NKTR & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$68.62

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Metalla Royalty & Streaming Ltd.

MTA

Metalla Royalty & Streaming Ltd.

HOLD

Current Price

$10.05

Market Cap

636.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTR
MTA
Founded
1990
1983
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
636.3M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
NKTR
MTA
Price
$68.62
$10.05
Analyst Decision
Strong Buy
Hold
Analyst Count
7
1
Target Price
$146.67
$9.00
AVG Volume (30 Days)
546.4K
301.0K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$307,711,000.00
N/A
Revenue This Year
N/A
$81.63
Revenue Next Year
N/A
$62.44
P/E Ratio
N/A
N/A
Revenue Growth
86.00
N/A
52 Week Low
$33.40
$5.88
52 Week High
$109.00
$11.60

Technical Indicators

Market Signals
Indicator
NKTR
MTA
Relative Strength Index (RSI) 42.22 51.22
Support Level $64.99 $9.82
Resistance Level $76.63 $11.60
Average True Range (ATR) 2.76 0.38
MACD -0.61 -0.16
Stochastic Oscillator 21.41 35.92

Price Performance

Historical Comparison
NKTR
MTA

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company that engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests. Geographically, the company generates revenue from Australia, Brazil, Mexico, and the USA, with the majority generated from Brazil.

Share on Social Networks: